Revvity (NYSE:RVTY) Sets New 12-Month Low - Here's Why

Key Points

• Revvity Inc. (NYSE:RVTY) reached a new 12-month low with the stock price trading as low as $84.63 and last at $84.98, down from a previous close of $87.87.
• Several equities analysts adjusted their price targets for Revvity, with Bank of America and Stifel Nicolaus both lowering their targets to $110.00 while maintaining a buy and hold rating respectively.
• Revvity announced a quarterly dividend of $0.07 per share, with the payment scheduled for November 7th, reflecting a forward yield of 0.3%.

Revvity Inc. (NYSE:RVTY - Get Free Report)'s stock price reached a new 52-week low on Wednesday . The company traded as low as $84.63 and last traded at $84.98, with a volume of 172017 shares changing hands. The stock had previously closed at $87.87.

Wall Street Analyst Weigh In

A number of equities analysts recently weighed in on RVTY shares. Bank of America lowered their price objective on shares of Revvity from $116.00 to $110.00 and set a "buy" rating on the stock in a research report on Thursday, June 26th. Stifel Nicolaus decreased their target price on shares of Revvity from $120.00 to $110.00 and set a "hold" rating on the stock in a research report on Tuesday, July 29th. Evercore ISI decreased their target price on shares of Revvity from $116.00 to $115.00 and set an "outperform" rating on the stock in a research report on Tuesday, July 8th. Raymond James Financial restated an "outperform" rating and set a $115.00 target price (down from $120.00) on shares of Revvity in a research report on Tuesday, July 29th. Finally, Wall Street Zen lowered shares of Revvity from a "buy" rating to a "hold" rating in a research report on Sunday, August 3rd. Ten analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company's stock. According to MarketBeat, Revvity has a consensus rating of "Moderate Buy" and an average price target of $120.07.

Revvity Stock Down 4.4%

The company has a debt-to-equity ratio of 0.43, a quick ratio of 2.75 and a current ratio of 3.33. The firm's 50-day moving average is $93.84 and its 200 day moving average is $97.69. The firm has a market capitalization of $9.75 billion, a PE ratio of 35.69, a price-to-earnings-growth ratio of 2.42 and a beta of 0.94.

Revvity (NYSE:RVTY - Get Free Report) last released its quarterly earnings data on Monday, July 28th. The company reported $1.18 EPS for the quarter, topping the consensus estimate of $1.14 by $0.04. Revvity had a net margin of 10.19% and a return on equity of 7.66%. The business had revenue of $720.28 million for the quarter, compared to analyst estimates of $711.26 million. During the same period in the previous year, the firm earned $1.22 EPS. The business's revenue for the quarter was up 4.1% compared to the same quarter last year. Revvity has set its FY 2025 guidance at 4.850-4.950 EPS. As a group, research analysts forecast that Revvity Inc. will post 4.94 earnings per share for the current fiscal year.

Revvity Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, November 7th. Shareholders of record on Friday, October 17th will be issued a $0.07 dividend. This represents a $0.28 dividend on an annualized basis and a yield of 0.3%. The ex-dividend date is Friday, October 17th. Revvity's dividend payout ratio is 11.86%.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in RVTY. Jane Street Group LLC lifted its holdings in Revvity by 222.0% in the 4th quarter. Jane Street Group LLC now owns 130,827 shares of the company's stock valued at $14,602,000 after purchasing an additional 90,198 shares in the last quarter. Mercer Global Advisors Inc. ADV lifted its holdings in Revvity by 11.7% in the 4th quarter. Mercer Global Advisors Inc. ADV now owns 15,119 shares of the company's stock valued at $1,687,000 after purchasing an additional 1,585 shares in the last quarter. AXA S.A. lifted its holdings in Revvity by 72.0% in the 4th quarter. AXA S.A. now owns 4,642 shares of the company's stock valued at $518,000 after purchasing an additional 1,943 shares in the last quarter. Ameriprise Financial Inc. lifted its holdings in Revvity by 40.4% in the 4th quarter. Ameriprise Financial Inc. now owns 74,252 shares of the company's stock valued at $8,287,000 after purchasing an additional 21,380 shares in the last quarter. Finally, BNP Paribas Financial Markets lifted its holdings in Revvity by 51.6% in the 4th quarter. BNP Paribas Financial Markets now owns 212,367 shares of the company's stock valued at $23,702,000 after purchasing an additional 72,255 shares in the last quarter. 86.65% of the stock is currently owned by hedge funds and other institutional investors.

Revvity Company Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.